Hanson & Doremus Investment Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.14M Buy
16,303
+463
+3% +$108K 0.42% 36
2026
Q1
$3.87M Buy
15,840
+2,022
+15% +$471K 0.45% 38
2025
Q4
$2.86M Buy
13,818
+585
+4% +$116K 0.34% 46
2025
Q3
$2.45M Sell
13,233
-18
-0.1% -$3.08K 0.31% 53
2025
Q2
$2.02M Sell
13,251
-1,976
-13% -$304K 0.27% 60
2025
Q1
$2.52M Buy
15,227
+1,349
+10% +$211K 0.37% 52
2024
Q4
$2.01M Buy
13,878
+1,271
+10% +$197K 0.31% 53
2024
Q3
$2.04M Sell
12,607
-208
-2% -$33.1K 0.32% 51
2024
Q2
$1.87M Sell
12,815
-414
-3% -$61.6K 0.31% 52
2024
Q1
$2.09M Buy
13,229
+9
+0.1% +$1.43K 0.36% 50
2023
Q4
$2.07M Buy
13,220
+40
+0.3% +$6.13K 0.39% 47
2023
Q3
$2.05M Sell
13,180
-841
-6% -$139K 0.42% 47
2023
Q2
$2.32M Buy
14,021
+482
+4% +$77.8K 0.48% 45
2023
Q1
$2.1M Sell
13,539
-2,980
-18% -$481K 0.47% 46
2022
Q4
$2.92M Buy
16,519
+1,879
+13% +$324K 0.63% 30
2022
Q3
$2.39M Buy
14,640
+257
+2% +$43.5K 0.62% 28
2022
Q2
$2.55M Sell
14,383
-78
-0.5% -$13.9K 0.62% 29
2022
Q1
$2.56M Buy
14,461
+314
+2% +$53.4K 0.55% 33
2021
Q4
$2.42M Hold
14,147
0.52% 33
2021
Q3
$2.29M Buy
14,147
+209
+1% +$35.7K 0.53% 34
2021
Q2
$2.08M Sell
13,938
-2,029
-13% -$336K 0.62% 28
2021
Q1
$2.62M Buy
15,967
+68
+0.4% +$11K 0.61% 33
2020
Q4
$2.5M Buy
15,899
+1,961
+14% +$289K 0.62% 31
2020
Q3
$2.08M Sell
13,938
-152
-1% -$22.5K 0.62% 28
2020
Q2
$1.98M Sell
14,090
-2,793
-17% -$407K 0.63% 28
2020
Q1
$2.21M Buy
16,883
+2,788
+20% +$396K 0.75% 28
2019
Q4
$2.06M Buy
14,095
+831
+6% +$113K 0.59% 36
2019
Q3
$1.72M Sell
13,264
-112
-0.8% -$14.8K 0.53% 42
2019
Q2
$1.86M Buy
13,376
+370
+3% +$51.2K 0.59% 38
2019
Q1
$1.82M Buy
13,006
+166
+1% +$22.2K 0.6% 40
2018
Q4
$1.66M Sell
12,840
-156
-1% -$21.8K 0.6% 40
2018
Q3
$1.8M Sell
12,996
-78
-0.6% -$10.4K 0.56% 46
2018
Q2
$1.59M Sell
13,074
-2,829
-18% -$353K 0.52% 49
2018
Q1
$2.04M Buy
15,903
+2,514
+19% +$340K 0.63% 41
2017
Q4
$1.87M Buy
13,389
+163
+1% +$22.7K 0.62% 41
2017
Q3
$1.72M Buy
13,226
+725
+6% +$96.1K 0.6% 43
2017
Q2
$1.65M Sell
12,501
-195
-2% -$24.9K 0.61% 42
2017
Q1
$1.58M Buy
12,696
+168
+1% +$20.1K 0.63% 42
2016
Q4
$1.44M Sell
12,528
-155
-1% -$17.9K 0.62% 44
2016
Q3
$1.5M Sell
12,683
-327
-3% -$39.7K 0.7% 40
2016
Q2
$1.58M Sell
13,010
-450
-3% -$51.1K 0.72% 37
2016
Q1
$1.46M Buy
13,460
+105
+0.8% +$10.9K 0.66% 41
2015
Q4
$1.37M Sell
13,355
-175
-1% -$17.6K 0.62% 44
2015
Q3
$1.26M Sell
13,530
-100
-0.7% -$9.67K 0.61% 48
2015
Q2
$1.33M Sell
13,630
-285
-2% -$28.5K 0.57% 51
2015
Q1
$1.4M Sell
13,915
-90
-0.6% -$9.15K 0.59% 47
2014
Q4
$1.47M Sell
14,005
-83
-0.6% -$8.75K 0.63% 45
2014
Q3
$1.5M Buy
14,088
+9
+0.1% +$933 0.68% 45
2014
Q2
$1.47M Sell
14,079
-80
-0.6% -$8.09K 0.68% 46
2014
Q1
$1.39M Hold
14,159
0.66% 48
2013
Q4
$1.3M Sell
14,159
-190
-1% -$17.5K 0.62% 50
2013
Q3
$1.24M Buy
14,349
+996
+7% +$89.4K 0.63% 49
2013
Q2
$1.15M Buy
+13,353
New +$1.13M 0.63% 52

Other funds holding JNJ

Hanson & Doremus Investment Management's JNJ Position: Q2 2026 in Review

Hanson & Doremus Investment Management increased its Johnson & Johnson (JNJ) stake by 2.9% in Q2 2026, buying an estimated $108K and bringing the position to 16,303 shares worth $4.14M. The position accounts for 0.42% of the portfolio, ranked #36.

Hanson & Doremus Investment Management first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Hanson & Doremus Investment Management held 16,303 shares of Johnson & Johnson worth $4.14M as of Q2 2026.
  • Hanson & Doremus Investment Management bought 463 Johnson & Johnson shares in Q2 2026, an estimated $108K.
  • Johnson & Johnson made up 0.42% of Hanson & Doremus Investment Management's portfolio in Q2 2026, its #36 holding.
  • Hanson & Doremus Investment Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Hanson & Doremus Investment Management's 13F filing for Q2 2026, filed 29 Jul 2026.